Company intelligence / Profile preview

Tulip

Ambala, Haryana, Indiaen.tulip-japan.co.jp ↗

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Tulip Biotech is an Indian pharmaceutical manufacturer established in 2015, producing a wide range of commercialized products including tablets, capsules, syrups, injections, and ayurvedic formulations. The company is ISO 9001:2015 certified and WHO-GMP compliant. No clinical trial data or novel drug development programs are reported.

Therapeutic areas: OtherRheumatologyInfectious Diseases
Modalities: Small moleculeHerbal/ayurvedic product
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Tulip.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tulip.

Explore the full profile